Jennifer Jarrett


Jennifer Jarrett has served as a member of our board of directors since September 2018. Since February 2019, Ms. Jarret has served as Vice President, Corporate Development and Capital Markets at Uber Technologies, a transportation network company. Prior to Uber, Ms. Jarrett was Chief Operating Officer and Chief Financial Officer of Arcus Biosciences, a biotechnology company, from March 2017 through January 2019 and she was Chief Financial Officer of Medivation, a biopharmaceutical company, which was acquired by Pfizer in 2016. Before Medivation, Ms. Jarrett spent 20 years in investment banking, most recently at Citigroup where she ran the firm’s west coast life sciences investment banking practice, and prior to that at Credit Suisse and Donaldson, Lufkin & Jenrette. Ms. Jarrett currently serves on the board of directors of Arena Pharmaceuticals and Arcus Biosciences, each of which is a publicly-traded company, and previously served on the board of Audentes Therapeutics. Ms. Jarrett received a B.A. in Economics from Dartmouth College and her M.B.A. from the Stanford Graduate School of Business.